Allison R Kaup1, Jasmine Nettiksimmons2, Erin S LeBlanc2, Kristine Yaffe2. 1. From Research Service (A.R.K.), San Francisco VA Medical Center (K.Y.); Departments of Psychiatry (A.R.K., J.N., K.Y.), Neurology (K.Y.), and Epidemiology and Biostatistics (K.Y.), University of California San Francisco; and Center for Health Research (E.S.L.), Kaiser Permanente Northwest, Portland, OR. allison.kaup@ucsf.edu. 2. From Research Service (A.R.K.), San Francisco VA Medical Center (K.Y.); Departments of Psychiatry (A.R.K., J.N., K.Y.), Neurology (K.Y.), and Epidemiology and Biostatistics (K.Y.), University of California San Francisco; and Center for Health Research (E.S.L.), Kaiser Permanente Northwest, Portland, OR.
Abstract
OBJECTIVES: To investigate the association between subjective memory complaints (SMCs) and long-term risk of cognitive impairment in aging because most previous studies have followed individuals for only a few years. METHODS: Participants were 1,107 cognitively normal, community-dwelling older women (aged 65 years and older at baseline) in a prospective study of aging. SMCs were assessed shortly after baseline and repeatedly over time with the yes/no question, "Do you feel you have more problems with memory than most?" Cognitive status 18 years later (normal or impaired with mild cognitive impairment or dementia) was determined by an expert panel. Using logistic regression, we investigated the association between SMCs over time and risk of cognitive impairment, adjusting for demographics, baseline cognition, and characteristics that differed between those with and without SMCs. RESULTS: At baseline, 8.0% of participants (n = 89) endorsed SMCs. Baseline SMCs were associated with increased risk of cognitive impairment 18 years later (adjusted odds ratio [OR] = 1.7, 95% confidence interval 1.1-2.8). Results were unchanged after excluding participants with depression. The association between SMCs and cognitive impairment was greatest at the last SMC assessment time point (18 years before diagnosis: adjusted OR = 1.7 [1.1-2.9]; 14 years before diagnosis: adjusted OR = 1.6 [0.9-2.7]; 10 years before diagnosis: adjusted OR = 1.9 [1.1-3.1]; 4 years before diagnosis: adjusted OR = 3.0 [1.8-5.0]). CONCLUSIONS: SMCs are associated with cognitive impairment nearly 2 decades later among older women. SMCs may be a very early symptom of an insidious neurodegenerative disease process, such as Alzheimer disease.
OBJECTIVES: To investigate the association between subjective memory complaints (SMCs) and long-term risk of cognitive impairment in aging because most previous studies have followed individuals for only a few years. METHODS:Participants were 1,107 cognitively normal, community-dwelling older women (aged 65 years and older at baseline) in a prospective study of aging. SMCs were assessed shortly after baseline and repeatedly over time with the yes/no question, "Do you feel you have more problems with memory than most?" Cognitive status 18 years later (normal or impaired with mild cognitive impairment or dementia) was determined by an expert panel. Using logistic regression, we investigated the association between SMCs over time and risk of cognitive impairment, adjusting for demographics, baseline cognition, and characteristics that differed between those with and without SMCs. RESULTS: At baseline, 8.0% of participants (n = 89) endorsed SMCs. Baseline SMCs were associated with increased risk of cognitive impairment 18 years later (adjusted odds ratio [OR] = 1.7, 95% confidence interval 1.1-2.8). Results were unchanged after excluding participants with depression. The association between SMCs and cognitive impairment was greatest at the last SMC assessment time point (18 years before diagnosis: adjusted OR = 1.7 [1.1-2.9]; 14 years before diagnosis: adjusted OR = 1.6 [0.9-2.7]; 10 years before diagnosis: adjusted OR = 1.9 [1.1-3.1]; 4 years before diagnosis: adjusted OR = 3.0 [1.8-5.0]). CONCLUSIONS: SMCs are associated with cognitive impairment nearly 2 decades later among older women. SMCs may be a very early symptom of an insidious neurodegenerative disease process, such as Alzheimer disease.
Authors: Gregory J Tranah; Terri Blackwell; Katie L Stone; Sonia Ancoli-Israel; Misti L Paudel; Kristine E Ensrud; Jane A Cauley; Susan Redline; Teresa A Hillier; Steven R Cummings; Kristine Yaffe Journal: Ann Neurol Date: 2011-11 Impact factor: 10.422
Authors: Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: Richard J Kryscio; Erin L Abner; Gregory E Cooper; David W Fardo; Gregory A Jicha; Peter T Nelson; Charles D Smith; Linda J Van Eldik; Lijie Wan; Frederick A Schmitt Journal: Neurology Date: 2014-09-24 Impact factor: 9.910
Authors: A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian Journal: Neurology Date: 2006-09-12 Impact factor: 9.910
Authors: Jessica Peter; Lukas Scheef; Ahmed Abdulkadir; Henning Boecker; Michael Heneka; Michael Wagner; Alexander Koppara; Stefan Klöppel; Frank Jessen Journal: Alzheimers Dement Date: 2013-07-15 Impact factor: 21.566
Authors: R Buckley; M M Saling; D Ames; C C Rowe; N T Lautenschlager; S L Macaulay; R N Martins; C L Masters; T O'Meara; G Savage; C Szoeke; V L Villemagne; K A Ellis Journal: Int Psychogeriatr Date: 2013-05-22 Impact factor: 3.878
Authors: Zoe Arvanitakis; Sue E Leurgans; Debra A Fleischman; Julie A Schneider; Kumar B Rajan; Jeremy J Pruzin; Raj C Shah; Denis A Evans; Lisa L Barnes; David A Bennett Journal: Ann Neurol Date: 2018-03-30 Impact factor: 10.422
Authors: Ian M McDonough; Graham J McDougall; Michael LaRocca; Safiya G Dalmida; Kristopher L Arheart Journal: Aging Ment Health Date: 2019-04-07 Impact factor: 3.658
Authors: Aliza P Wingo; Thomas S Wingo; Wen Fan; Sharon Bergquist; Alvaro Alonso; Michele Marcus; Allan I Levey; James J Lah Journal: J Affect Disord Date: 2019-11-30 Impact factor: 4.839
Authors: Lennard L van Wanrooij; Edo Richard; Susan Jongstra; Eric P Moll van Charante; Willem A van Gool Journal: Ann Fam Med Date: 2019-09 Impact factor: 5.166